← Eichor
Study identifier: NCT07438912 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Mind After Midnight

Condition: Suicidal Ideation · Circadian Rhythm Disorders · Sleep Deprivation  ·  Sponsor: University of Arizona

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

This study examines whether wakefulness during the biological night (2:00-4:00 AM) is associated with increased negative mood, impaired decision-making, and suicidal thoughts. Adults with a history of suicidal ideation in the past six months will complete laboratory and home-based assessments under varying levels of sleep pressure. Participants will be evaluated during late-night wakefulness and under conditions of both higher and lower sleep pressure. The goal of the study is to better understand the biological and behavioral mechanisms that may contribute to elevated suicide risk during nocturnal wakefulness.

This description comes directly from the study's public registry record.

Talk to the study team

Denisse Armenta  ·  5206261737  ·  armentamd@arizona.edu

Darilyn Rivera-Collazo, MS  ·  5206264746  ·  darilyn@arizona.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Arizona - Center for Sleep, Circadian, and Neuroscience ResearchTucson, Arizona, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07438912